Course Overview
Significant advances in the diagnosis and management of heart failure and arrhythmias continue to emerge, compelling the practice of cardiology to constantly evolve. These advances must be consistently implemented into clinical practice to guarantee the best care for patients affected by these cardiovascular conditions. The Clinical Advances in Heart Failure, Arrhythmias, and Cardiogenic Shock Symposium is designed to assist clinicians in correctly diagnosing, treating, and managing patients with arrhythmias and heart failure as well as optimally managing those with cardiogenic shock. The symposium is dedicated to providing insight and practical tips with regard to integrating scientific evidence into clinical practice. Faculty will also cover a variety of co-morbid and chronic conditions patients with heart disease may face. The goal of the conference is for participants to return to their facilities equipped with the latest evidence base and strategies to improve patient outcomes.

Educational Objectives
After attending this live activity, participants should be able to:
• Incorporate current and emerging clinical evidence in the assessment, treatment, and management of patients with challenging cardiovascular disease.
• Identify guideline-recommended treatment algorithms for heart failure.
• Compare pharmacological and device therapies for cardiogenic shock.
• Assess device-based therapies for heart rhythm disorders.
• Identify racial and gender disparities in cardiac device selection.
• Employ new interdisciplinary care team strategies to enhance the prevention, diagnosis, and management of various types of heart disease.
• Determine the effect of comorbidity and chronic conditions on patients with heart disease.

Target Audience
• Cardiologists
• Electrophysiologists
• Internists
• Cardiology Nurses/Nurse Practitioners/Physician Assistants
• Cardiovascular Technicians
• Sonographers

+ Topics:

brochure_heart23.pdf
Session 1 Heart Failure Reading Between the Guidelines.mp4
Session 1 New Medications and Guideline Based Therapy for Heart Failure.mp4
Session 1 Panel Discussion Q&A.mp4
Session 1 What’s New in Cardiology 2023.mp4
Session 1 What’s New in Pulmonary Hypertension.mp4
Session 2 Current and Emerging Approaches to Amyloidosis.mp4
Session 2 Hypertrophic Cardiomyopathy.mp4
Session 2 In-patient Management of Heart Failure.mp4
Session 2 New Treatments for HFpFF.mp4
Session 2 Panel Discussion Q&A.mp4
Session 3 A. Antiarrhythmic Therapy and Pacemaker & Defibrillator Rhythm Identification.mp4
Session 3 B. Advanced Imaging in Heart Failure.mp4
Session 3 C. Sharks in the Water.mp4
Session 4 Advanced Medical Therapy for Shock How to Choose Which Drug.mp4
Session 4 Back to Basics CPR, Resuscitation and POCUS for Shock.mp4
Session 4 Panel Discussion Q&A.mp4
Session 4 Staging of Shock.mp4
Session 4 Which Device for Which Patient in Shock.mp4
Session 5 Advanced Therapies.mp4
Session 5 ECMO in Cardiogenic Shock.mp4
Session 5 Panel Discussion Q&A.mp4
Session 5 Shock with Pulmonary Emboli.mp4
Session 6 D. Juggling Heart Failure Medications.mp4
Session 6 E. ICM Patient Selection and Implant Techniques.mp4
Session 6 F. AF Stroke Prevention Anticoagulation vs. LAAO The Benefits and Risks.mp4
Session 7 Diabetes and Heart Disease.mp4
Session 7 Lipids Update.mp4
Session 7 Obesity and Heart Failure.mp4
Session 7 Panel Discussion Q&A.mp4
Session 8 Advances in Physiologic Pacing.mp4
Session 8 Leadless Pacemakers.mp4
Session 8 Panel Discussion Q&A.mp4
Session 8 Pulsed-Field Ablation to Treat Atrial Fibrillation.mp4
Session 8 Racial and Gender Disparity in Cardiac Device Selection.mp4
Session 9 Arrhythmia and Palpitations in Women.mp4
Session 9 Autonomic Dysfunction Signs, Symptoms, and Treatments.mp4
Session 9 Panel Discussion Q&A.mp4
Session 9 Ventricular Tachycardia.mp4brochure_heart23.pdf
Session 1 Heart Failure Reading Between the Guidelines.mp4
Session 1 New Medications and Guideline Based Therapy for Heart Failure.mp4
Session 1 Panel Discussion Q&A.mp4
Session 1 What’s New in Cardiology 2023.mp4
Session 1 What’s New in Pulmonary Hypertension.mp4
Session 2 Current and Emerging Approaches to Amyloidosis.mp4
Session 2 Hypertrophic Cardiomyopathy.mp4
Session 2 In-patient Management of Heart Failure.mp4
Session 2 New Treatments for HFpFF.mp4
Session 2 Panel Discussion Q&A.mp4

Session 3 A. Antiarrhythmic Therapy and Pacemaker & Defibrillator Rhythm Identification.mp4
Session 3 B. Advanced Imaging in Heart Failure.mp4
Session 3 C. Sharks in the Water.mp4
Session 4 Advanced Medical Therapy for Shock How to Choose Which Drug.mp4
Session 4 Back to Basics CPR, Resuscitation and POCUS for Shock.mp4
Session 4 Panel Discussion Q&A.mp4
Session 4 Staging of Shock.mp4
Session 4 Which Device for Which Patient in Shock.mp4
Session 5 Advanced Therapies.mp4
Session 5 ECMO in Cardiogenic Shock.mp4
Session 5 Panel Discussion Q&A.mp4
Session 5 Shock with Pulmonary Emboli.mp4
Session 6 D. Juggling Heart Failure Medications.mp4
Session 6 E. ICM Patient Selection and Implant Techniques.mp4
Session 6 F. AF Stroke Prevention Anticoagulation vs. LAAO The Benefits and Risks.mp4
Session 7 Diabetes and Heart Disease.mp4
Session 7 Lipids Update.mp4
Session 7 Obesity and Heart Failure.mp4
Session 7 Panel Discussion Q&A.mp4
Session 8 Advances in Physiologic Pacing.mp4
Session 8 Leadless Pacemakers.mp4
Session 8 Panel Discussion Q&A.mp4
Session 8 Pulsed-Field Ablation to Treat Atrial Fibrillation.mp4
Session 8 Racial and Gender Disparity in Cardiac Device Selection.mp4
Session 9 Arrhythmia and Palpitations in Women.mp4
Session 9 Autonomic Dysfunction Signs, Symptoms, and Treatments.mp4
Session 9 Panel Discussion Q&A.mp4
Session 9 Ventricular Tachycardia.mp4